Sylvia Cheung | Chief Financial Officer |
Joseph Darling | President and Chief Executive Officer |
Mike Petusky | Barrington Research |
Joe Munda | First Analysis |
Jim Sidoti | Sidoti & Company |
Good evening, ladies and gentlemen, and welcome to the Anika Therapeutics First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call may be recorded. I would now like to introduce your host for today’s conference, Sylvia Cheung, Chief Financial Officer.